Latest Conference Articles

Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community.

POLL: Are you attending AAO in Chicago?

POLL: Are you attending AAO in Chicago?

September 22nd 2022

AAO

We're polling ophthalmologists about attendance at the 2022 American Academy of Ophthalmology Meeting in Chicago, Illinois. The poll will be open until September 28, 2022.

EP. 1: EyeCon 2022: Nothing is better than in-person conferences

EP. 1: EyeCon 2022: Nothing is better than in-person conferences

September 21st 2022

EyeCon

Co-chairs Peter J. McDonnell, MD, director of the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Oluwatosin U. Smith, MD, of Glaucoma Associates of Texas in Dallas break down the top reasons to attend this year's Ophthalmology Times® EyeCon 2022 in a series of video segments.

EyeCon 2022: Keeping updates in cataract and refractive surgery in focus

EyeCon 2022: Keeping updates in cataract and refractive surgery in focus

September 18th 2022

EyeCon

Elizabeth Yeu, MD, will highlight pearls for managing intraocular lenses in difficult cases.

EURETINA 2022: Stepping into a new era in ophthalmology

EURETINA 2022: Stepping into a new era in ophthalmology

August 30th 2022

EURETINA

The 22nd European Society of Retina Specialists Congress kicks off Thursday at the Congress Centre Hamburg in Hamburg, Germany.

Ophthalmology to take the Windy City by storm

Ophthalmology to take the Windy City by storm

August 30th 2022

AAO

The American Academy of Ophthalmology annual meeting is coming to Chicago, Illinois from September 30 to October 3, featuring Subspecialty Days and a virtual component. The event will be held at Chicago’s McCormick Place, billed as the largest convention center in North America and located on the shore of Lake Michigan.

Ophthalmology Times® to host EyeCon 2022

Ophthalmology Times® to host EyeCon 2022

August 8th 2022

EyeCon

Industry leaders will come together Dec. 16-17 in Marco Island, Florida, to present the latest data and treatments.

Wykoff: RGX-314 highlights DRSS improvements in patients diagnosed with DME, NPDR

Wykoff: RGX-314 highlights DRSS improvements in patients diagnosed with DME, NPDR

July 19th 2022

ASRS Preview

Charles Wykoff, MD, took the stage at the American Society of Retina Specialists annual meeting in New York to present a talk titled “Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy: Phase II ALTITUDE Study.” He discusses results of the trial, which showed improvements for patients diagnosed with diabetic macular edema and non-proliferative diabetic retinopathy, with notable improvements according to the Diabetic Retinopathy Severity Scale.

ASRS LIVE: Anatomic/functional outcomes of various surgical approaches for progressive RDs Secondary to retinoschisis

ASRS LIVE: Anatomic/functional outcomes of various surgical approaches for progressive RDs Secondary to retinoschisis

July 16th 2022

ASRS

Speaking at the American Society of Retina Specialists 2022 annual meeting at the Jacob K. Javits Convention Center in New York, J. Fernando Arevalo, MD, PhD, The Edmund F. and Virginia B. Ball Professor of Ophthalmology, chairman of ophthalmology at Johns Hopkins Bayview Medical Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, outlined his investigation of the anatomic and functional outcomes of pars plana vitrectomy, scleral buckle, or a combination of the 2, and suggested that the combination approach may need further consideration.

ASRS LIVE: TRUCKEE Study shows real-world safety and efficacy of faricimab for neovascular AMD

ASRS LIVE: TRUCKEE Study shows real-world safety and efficacy of faricimab for neovascular AMD

July 16th 2022

ASRS

Speaking at the American Society of Retina Specialists 2022 annual meeting in New York, Carl Danzig, MD, detailed how treatment with faricimab in patients with neovascular AMD resulted in improvements in visual acuity, central subfield thickness and pigment epithelial detachments.

ASRS LIVE: Tools developed to identify risk of vision loss to diabetic retinopathy

ASRS LIVE: Tools developed to identify risk of vision loss to diabetic retinopathy

July 15th 2022

ASRS

During a presentation at the American Society of Retina Specialists 2022 annual meeting in New York, Bobeck S. Modjtahedi, MD, presented results of a study that examined the accuracy of tools for predicting the risk of vision-threatening diabetic retinopathy.